Protein Design Labs (PDLI): Stock strong

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Protein Design Labs (PDLI): Stock strong

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
407	58	0	PDLI

Emcee: Stanley Cowen	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
82	Medimmune Buys Out Certain Synagis(TM) Royalty Obligations. biz.yahoo.com The	Dave L	-	6/17/1998
81	Their lead product, Zenapax, is being marketed by Roche, and Roche is not sayin	Michael Olin	-	6/17/1998
80	Yes Biotech is weak in general - but PDLI has even been much weaker than the	Spekulatius	-	6/17/1998
79	The Biotech index is getting killed. It recently broke support. iqc.com I thi	fut_trade	-	6/17/1998
78	Any Idea why this stock is getting killed?	Spekulatius	-	6/16/1998
77	PDLI is gapping up this morning. It looks like a rally.	fut_trade	-	4/15/1998
76	Added to my position today. I think we are near the bottom. Peter	fut_trade	-	4/10/1998
75	Insider selling. From insidertrader.com	fut_trade	-	4/7/1998
74	Peter -- Would you clarify? Thanks -- Bill	Bill Mowat	-	4/7/1998
73	This is why the stock is dropping: 144 367,875 9,000 1 - D 40.88 3/27/98	fut_trade	-	3/29/1998
72	The only recent news I am aware of is in the link below: techstocks.com Peter	fut_trade	-	3/29/1998
71	Peter, any news to account for the down drift? dp	Dulane U. Ponder	-	3/28/1998
70	PDLI is trending down. Soros is still holding his position as of March 6. Are	fut_trade	-	3/28/1998
69	You wrote: <<M.Geller of CIBC estimates Zenapax can have sales of over $1	Biomaven	-	2/24/1998
68	The researchers report Zenapax's rejection episodes to be "mild"	John S. Sturges	-	2/24/1998
67	John..I have followed your posts with interest. I was curious as to the "m	Larry Liebman	-	2/23/1998
66	Cyclosporin vs Zenapax, 2 top transplant centers choose Zenapax. Last week the	John S. Sturges	-	2/17/1998
65	BIG, BIG MOVE Ahead!! PDLI to present in Europe Feb 14th and 18th. data on Zena	John S. Sturges	-	2/12/1998
64	Michael, There persists a significant effort to sell this stock short. Soros ma	John S. Sturges	-	2/3/1998
63	I just spoke to one of my contacts at Roche, figuring they might know something	Michael Olin	-	2/3/1998
62	Michael -- my question also. I've heard nothing. In fact my broker at OPC	Dulane U. Ponder	-	2/3/1998
61	Volume is up, price down more than 2 points. Has anyone seen any news or have a	Michael Olin	-	2/3/1998
60	Good info. Thanks for the heads-up. Very likely 3-4yrs away. Best regards, John	John S. Sturges	-	2/1/1998
59	fyi, interesting pre-clinical study ... no indication whether the researchers	Peter Singleton	-	1/29/1998
58	The Feb. 18th. conference should give some lift. I have used margin as well. Sh	John S. Sturges	-	1/28/1998

Go to reply# or date (mm/dd/yy):